|

Carboplatin for Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Shanghai Hengrui Pharmaceutical Co., Ltd.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Cancer2
  • Early-stage or Locally Advanced HER2-positive Breast Cancer1
  • Advanced Solid Tumors1
  • Breast Cancer1

Other2 trials

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Phase 1/2
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.